Mkts

BioAtla, Inc.

NASDAQ: BCAB
$1.99+0.43 (+27.56%)
As of Nov 15, 7:00 PM ET

Key statistics

Day range
1.762.01
52-week range
1.0771.50
Today
Open1.79
Previous close1.99
Volume1.4K
Valuation
Market cap3.32M
P/E ratio—
EPS (TTM)-25.56
Income & risk
Dividend / yield—
Beta0.62
Avg volume44.9K
Discussion

BCAB News

Stories mentioning BCAB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development4,5827,9959,53913,68412,35511,65016,39516,198
Sales General & Admin
Total Operating Expenses9,30811,25513,78918,64717,61416,24422,27021,972
Operating Income (Loss)(9,308)(9,255)(13,789)(18,647)(17,614)(16,244)(11,270)(21,972)
Interest Income37.0077.00133.00233.00400.00554.00692.00900.00
Interest Expense
Other Expense2,964(529.00)(1,989)(64.00)2,2801,360684.00900.00
Pretax Income
Tax Provision
Net Income (Loss)(6,344)(9,784)(15,778)(18,711)(15,334)(14,884)(10,586)(21,072)
Earnings Per Share (Basic)(4.22)(0.17)(0.27)(0.32)(13.16)(0.31)(0.22)(0.44)
Earnings Per Share (Diluted)(4.22)(0.17)(0.27)(0.32)(13.16)(0.31)(0.22)(0.44)
Weighted Average Shares Outstanding (Basic)1,50258,82858,74558,5041,16548,57348,33648,215
Weighted Average Shares Outstanding (Diluted)1,50258,82858,74558,5041,16548,57348,33648,215

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BCAB

BioAtla, Inc. (NASDAQ: BCAB) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCAB. It last traded at $1.99 (Nov 15, 2026, 7:00 PM ET), up 27.6% on the day. That gives BioAtla a market capitalisation of $3.3M.

Over the past 52 weeks BCAB has traded between $1.07 and $71.50.

For the quarter ended Mar 31, 2026 it reported a net loss of $6.3M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$6.3M
Dec 31, 2025—-$9.8M
Sep 30, 2025—-$15.8M
Jun 30, 2025—-$18.7M

From BioAtla’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…